Search Results Search Sort by RelevanceMost Recent State of the Art and Science Feb 2017 Reasonableness, Credibility, and Clinical Disagreement Mary Jean Walker, PhD and Wendy A. Rogers, BMBS, PhD When is a source credible and how do beliefs about a source’s credibility influence assessments of evidence? AMA J Ethics. 2017;19(2):176-182. doi: 10.1001/journalofethics.2017.19.2.stas1-1702. Case and Commentary Apr 2016 Prenatal Risk Assessment and Diagnosis of Down Syndrome: Strategies for Communicating Well with Patients Eva Schwartz, MD and Kishore Vellody, MD Physicians should provide women considering abortion after Down syndrome screening with unbiased information and not attempt to influence their decision. AMA J Ethics. 2016;18(4):359-364. doi: 10.1001/journalofethics.2016.18.4.ecas1-1604. Case and Commentary Feb 2023 How Should Clinicians Minimize Bias When Responding to Suspicions About Child Abuse? Megan M. Letson, MD, MEd and Kristin G. Crichton, DO, MPH Following evidence-based approaches to evaluating and reporting suspicion of child maltreatment can help minimize bias and promote equity. AMA J Ethics. 2023;25(2):E93-99. doi: 10.1001/amajethics.2023.93. In the Literature Mar 2005 Black Box Blues: Kids and Antidepressants Louis J. Kraus, MD and Renee Mehlinger, MD Virtual Mentor. 2005;7(3):222-226. doi: 10.1001/virtualmentor.2005.7.3.jdsc1-0503. Case and Commentary Jun 2006 Unnecessary Antibiotics Jonathan A. Finkelstein, MD, MPH Virtual Mentor. 2006;8(6):362-366. doi: 10.1001/virtualmentor.2006.8.6.ccas1-0606. State of the Art and Science Oct 2006 Diagnosis and Treatment of Conduct Disorder Suma Jacob, MD, PhD Virtual Mentor. 2006;8(10):672-675. doi: 10.1001/virtualmentor.2006.8.10.cprl1-0610. Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 1 Courtenay R. Bruce, JD and Anne Lederman Flamm, JD Virtual Mentor. 2009;11(3):207-211. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903. Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 2 Thomas W. LeBlanc, MD, MA and Philip M. Rosoff, MD, MA Virtual Mentor. 2009;11(3):211-214. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903. Policy Forum Aug 2008 Role of Independent Advocates for Research Subjects Who Are Child Wards of the State Hafzah Mueenuddin, JD and Eric D. Kodish, MD Virtual Mentor. 2008;10(8):524-526. doi: 10.1001/virtualmentor.2008.10.8.pfor1-0808. State of the Art and Science Dec 2005 Diagnosing Pediatric Lead Toxicity Jennifer Reenan, MD Virtual Mentor. 2005;7(12):798-802. doi: 10.1001/virtualmentor.2005.7.12.cprl1-0512. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
State of the Art and Science Feb 2017 Reasonableness, Credibility, and Clinical Disagreement Mary Jean Walker, PhD and Wendy A. Rogers, BMBS, PhD When is a source credible and how do beliefs about a source’s credibility influence assessments of evidence? AMA J Ethics. 2017;19(2):176-182. doi: 10.1001/journalofethics.2017.19.2.stas1-1702.
Case and Commentary Apr 2016 Prenatal Risk Assessment and Diagnosis of Down Syndrome: Strategies for Communicating Well with Patients Eva Schwartz, MD and Kishore Vellody, MD Physicians should provide women considering abortion after Down syndrome screening with unbiased information and not attempt to influence their decision. AMA J Ethics. 2016;18(4):359-364. doi: 10.1001/journalofethics.2016.18.4.ecas1-1604.
Case and Commentary Feb 2023 How Should Clinicians Minimize Bias When Responding to Suspicions About Child Abuse? Megan M. Letson, MD, MEd and Kristin G. Crichton, DO, MPH Following evidence-based approaches to evaluating and reporting suspicion of child maltreatment can help minimize bias and promote equity. AMA J Ethics. 2023;25(2):E93-99. doi: 10.1001/amajethics.2023.93.
In the Literature Mar 2005 Black Box Blues: Kids and Antidepressants Louis J. Kraus, MD and Renee Mehlinger, MD Virtual Mentor. 2005;7(3):222-226. doi: 10.1001/virtualmentor.2005.7.3.jdsc1-0503.
Case and Commentary Jun 2006 Unnecessary Antibiotics Jonathan A. Finkelstein, MD, MPH Virtual Mentor. 2006;8(6):362-366. doi: 10.1001/virtualmentor.2006.8.6.ccas1-0606.
State of the Art and Science Oct 2006 Diagnosis and Treatment of Conduct Disorder Suma Jacob, MD, PhD Virtual Mentor. 2006;8(10):672-675. doi: 10.1001/virtualmentor.2006.8.10.cprl1-0610.
Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 1 Courtenay R. Bruce, JD and Anne Lederman Flamm, JD Virtual Mentor. 2009;11(3):207-211. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903.
Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 2 Thomas W. LeBlanc, MD, MA and Philip M. Rosoff, MD, MA Virtual Mentor. 2009;11(3):211-214. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903.
Policy Forum Aug 2008 Role of Independent Advocates for Research Subjects Who Are Child Wards of the State Hafzah Mueenuddin, JD and Eric D. Kodish, MD Virtual Mentor. 2008;10(8):524-526. doi: 10.1001/virtualmentor.2008.10.8.pfor1-0808.
State of the Art and Science Dec 2005 Diagnosing Pediatric Lead Toxicity Jennifer Reenan, MD Virtual Mentor. 2005;7(12):798-802. doi: 10.1001/virtualmentor.2005.7.12.cprl1-0512.